Tutorials › Bioavailability and Bioequivalence › Trough Concentrations And Peak-To-Trough Fluctuation

Fed, Fasted and Multiple-Dose Studies · Tutorial 169 of 399

Trough Concentrations And Peak-To-Trough Fluctuation

Learn to identify the steady-state trough, calculate peak-to-trough fluctuation and interpret how the dosing interval shapes concentration variation.

Intermediate 9 min read

What You'll Learn

  • Define steady-state trough concentration and distinguish it from the peak within a dosing interval.
  • Calculate average steady-state concentration from AUC over the dosing interval.
  • Compute and interpret peak-to-trough fluctuation and the peak-to-trough ratio.
  • Derive the interval-dependent fluctuation in an idealized bolus-dose model.
  • Compare observed profile summaries with model-based predictions and recognize their limitations.
  • Diagnose how sparse sampling, assay limits, and inconsistent definitions can distort fluctuation estimates.

Why trough and fluctuation matter

At steady state, concentrations still rise and fall during each dosing interval. AUC over the interval summarizes total exposure, but it does not reveal how much concentration varies between the interval’s peak and its low point. The trough concentration describes that low point, while peak-to-trough fluctuation relates the peak-to-trough difference to average concentration. These summaries help describe the concentration profile over time; neither, by itself, establishes clinical effectiveness or safety.

The trough is usually the concentration immediately before the next scheduled dose. For an oral drug, the maximum concentration may occur some time after dosing, so it should not automatically be treated as the concentration at the instant the dose is administered. A reliable estimate requires samples timed across the interval, including a sample close to the next dose, as discussed in the earlier material on sampling across a steady-state dosing interval.

Definition: At steady state, \(C_{\min,ss}\) is the minimum concentration during one dosing interval, commonly estimated by the predose concentration immediately before the next dose. \(C_{\max,ss}\) is the maximum concentration during that interval. The average concentration is \(C_{\mathrm{avg},ss}=AUC_{\tau,ss}/\tau\), where \(AUC_{\tau,ss}\) is the area under the concentration-time curve over the interval of length \(\tau\). The peak-to-trough fluctuation is \((C_{\max,ss}-C_{\min,ss})/C_{\mathrm{avg},ss}\), often reported as a percentage. The peak-to-trough ratio is \(C_{\max,ss}/C_{\min,ss}\), provided \(C_{\min,ss}>0\).

The fluctuation percentage is a normalized difference: it describes the peak-to-trough range relative to the interval average. It is not a percent change from the trough. The peak-to-trough ratio, by contrast, compares the peak directly with the trough. Report concentrations with units, and state clearly which fluctuation definition is being used.

Calculating the summaries from a profile

For a measured concentration-time profile, identify the highest concentration observed within the interval and the concentration closest to the next dose. Estimate \(AUC_{\tau,ss}\) over the same interval, then divide by \(\tau\) to obtain the average. When AUC is calculated from sampled concentrations, the method used to connect observations (for example, a linear trapezoidal rule) and the adequacy of sampling affect the estimate. The largest observed concentration is not necessarily the true maximum if sampling misses the actual peak.

Worked Example: Summarizing a Hypothetical Steady-State Profile

Suppose a hypothetical 12-hour dosing interval has a predose concentration of 3.2 mg/L. The highest sampled concentration is 8.1 mg/L, and the estimated \(AUC_{\tau,ss}\) is 72 mg·h/L. Treat the highest sampled value as the observed peak for this calculation.

Average concentration. Divide AUC by the 12-hour interval:

$$ C_{\mathrm{avg},ss}=\frac{AUC_{\tau,ss}}{\tau} =\frac{72\ \mathrm{mg\cdot h/L}}{12\ \mathrm{h}} =6.00\ \mathrm{mg/L}. $$

Fluctuation. The observed peak-to-trough difference is \(8.1-3.2=4.9\) mg/L. Relative to the average, the fluctuation is:

$$ \frac{8.1-3.2}{6.00}\times100\% =81.7\%. $$

Peak-to-trough ratio. Dividing the observed peak by the predose trough gives \(8.1/3.2=2.531\). Thus the observed peak is 2.531 times the trough. These estimates describe this hypothetical interval; sparse sampling could mean the actual maximum was higher than 8.1 mg/L.

Why the dosing interval changes fluctuation

An idealized model makes the role of the dosing interval explicit. Assume repeated instantaneous doses into a one-compartment system, first-order elimination with rate constant \(k\), linear pharmacokinetics, and complete dose delivery. Assume the system has reached steady state, so concentrations from successive doses add and the concentration decays exponentially between doses. This is a simplifying model, not a general description of every oral concentration profile.

Let \(D/V\) denote the concentration increment from one dose, where \(D\) is dose and \(V\) is apparent volume of distribution. With dosing interval \(\tau\), the trough just before a dose is the post-dose peak from the preceding interval multiplied by the fraction remaining after \(\tau\), \(e^{-k\tau}\). At steady state, the peak equals the concentration increment plus the residual trough. Solving these relationships gives:

$$ C_{\max,ss}=\frac{D/V}{1-e^{-k\tau}}, \qquad C_{\min,ss}=C_{\max,ss}e^{-k\tau}. $$

The average concentration in this idealized model is the dose per interval divided by clearance and interval length. Since \(CL=kV\), this is \(C_{\mathrm{avg},ss}=(D/V)/(k\tau)\). The model therefore implies a particularly simple result for fluctuation.

Derivation: Subtract the trough from the peak using the steady-state equations: \(C_{\max,ss}-C_{\min,ss}=C_{\max,ss}(1-e^{-k\tau})=D/V\). Divide by \(C_{\mathrm{avg},ss}=(D/V)/(k\tau)\). The factors \(D/V\) cancel, leaving \((C_{\max,ss}-C_{\min,ss})/C_{\mathrm{avg},ss}=k\tau\). Thus, in this idealized model, percentage fluctuation is \(100k\tau\%\). Also, \(C_{\max,ss}/C_{\min,ss}=e^{k\tau}\).

The dimensionless product \(k\tau\) governs the relative swing in this model. For a fixed elimination rate, a longer interval gives more time for elimination before the next dose, increasing fluctuation and the peak-to-trough ratio. A shorter interval reduces the swing. These identities depend on the stated bolus and first-order assumptions; they should not be applied as exact relationships to a measured oral profile with absorption and a delayed peak.

Worked Example: Comparing Two Intervals at the Same Average Concentration

Consider two hypothetical bolus regimens with the same elimination rate, \(k=0.100\ \mathrm{h}^{-1}\), and a target average concentration of 6.00 mg/L. To maintain that average in the model, \(D/V=C_{\mathrm{avg},ss}k\tau\). The dose-per-volume increments are therefore 4.80 mg/L for an 8-hour interval and 7.20 mg/L for a 12-hour interval.

Eight-hour interval. Here \(k\tau=0.800\) and \(e^{-0.800}=0.449329\). Thus:

$$ C_{\max,ss}=\frac{4.80}{1-0.449329}=8.7166\ \mathrm{mg/L}, \qquad C_{\min,ss}=8.7166(0.449329)=3.9166\ \mathrm{mg/L}. $$

The difference is approximately \(4.800\) mg/L, so fluctuation is \((4.800/6.00)\times100\%=80.0\%\). The peak-to-trough ratio is \(8.7166/3.9166=2.226\), consistent with \(e^{0.800}=2.22554\), which rounds to 2.226.

Twelve-hour interval. Here \(k\tau=1.20\) and \(e^{-1.20}=0.301194\). Using the corresponding 7.20 mg/L increment:

$$ C_{\max,ss}=\frac{7.20}{1-0.301194}=10.3033\ \mathrm{mg/L}, \qquad C_{\min,ss}=10.3033(0.301194)=3.1033\ \mathrm{mg/L}. $$

The peak-to-trough difference is 7.20 mg/L, giving fluctuation \((7.20/6.00)\times100\%=120.0\%\). The ratio is \(10.3033/3.1033=3.320\), also given by \(e^{1.20}\approx3.32012\). Both regimens have the same modeled average, but the 12-hour interval has the greater relative swing. The comparison changes dose per interval to keep average concentration fixed; it is not a same-dose comparison.

Interpreting results and checking assumptions

Observed fluctuation and the model-based result answer related but distinct questions. A profile-based estimate summarizes sampled concentrations and AUC under a particular study and sampling scheme. A model-based calculation predicts the profile under specified kinetic assumptions. The model is useful for understanding how interval length can shape variation, but measured data take precedence when estimating a participant’s actual profile.

Before interpreting either result, check that the interval is at steady state and that the concentrations and AUC refer to the same interval. A predose value only represents the trough well if its collection time is close to the next dose and the dosing schedule was followed. Also check assay performance, sample handling, and the timing and density of samples around the expected peak and trough. A trough below the assay’s quantification limit cannot simply be treated as an exact zero: doing so makes the ratio undefined and can inflate or misrepresent fluctuation.

A common mistake is to divide the peak-to-trough difference by the trough and call the result “fluctuation.” That calculation, \((C_{\max,ss}-C_{\min,ss})/C_{\min,ss}\), is a percent increase relative to the trough, not the fluctuation definition used here. For example, with a peak of 8.1 mg/L, trough of 3.2 mg/L, and average of 6.00 mg/L, the defined fluctuation is 81.7%, while the increase relative to trough is 153%. The numbers differ because their denominators represent different reference concentrations.

Another pitfall is treating the largest sampled value as the true peak without qualification. If samples are widely spaced around the anticipated peak, the observed maximum can miss it; interpolation or a pharmacokinetic model may help, but each adds assumptions. Similarly, noisy concentrations near the trough can make the minimum highly sensitive to a single measurement. Report how the peak and trough were selected or estimated, the interval, and the average concentration used in the calculation.

ApproachStrengthMain limitation
Observed profile summariesDirectly describe the measured interval and require few kinetic assumptions.Depend on sampling times, assay quality, and how peak and trough are estimated.
Idealized bolus modelShows explicitly how \(k\tau\) controls relative fluctuation under its assumptions.May not represent absorption, delayed peaks, or other departures from the model.
Peak-to-trough ratioProvides an intuitive multiplicative comparison between peak and trough.Does not normalize the difference by average concentration and is unstable when trough is near zero.

These endpoints are descriptive pharmacokinetic summaries. A larger fluctuation indicates a wider peak-to-trough range relative to the average under the stated definition; it does not alone establish that a regimen is inadequate. Clinical interpretation depends on the drug, therapeutic context, concentration-response information, and other relevant evidence. The measured profile also has uncertainty, which a single summary does not display.

Worked Example: Interpreting a Hypothetical Second Profile

A hypothetical 12-hour steady-state profile has \(AUC_{\tau,ss}=78\) mg·h/L, a peak of 9.0 mg/L, and a predose trough of 4.5 mg/L. The average concentration is \(78/12=6.50\) mg/L. The peak-to-trough difference is \(9.0-4.5=4.5\) mg/L, so fluctuation is \((4.5/6.50)\times100\%=69.2\%\). The peak-to-trough ratio is \(9.0/4.5=2.00\). In context, the sampled peak is twice the predose trough, and the peak-to-trough range is 69.2% of the interval average. This result should not be compared with another profile unless the endpoint definition and estimation methods are consistent.

Check Your Understanding

Use the definitions above. Solutions are included so that each calculation can be checked.

  1. A 10-hour interval has \(AUC_{\tau,ss}=50\) mg·h/L, peak 7.0 mg/L, and trough 3.0 mg/L. Find average concentration, fluctuation, and peak-to-trough ratio.
  2. In the idealized bolus model, \(k=0.08\ \mathrm{h}^{-1}\) and \(\tau=10\) h. What are the predicted percentage fluctuation and peak-to-trough ratio?
  3. Why can the highest sampled concentration underestimate \(C_{\max,ss}\)?
  4. Why is a trough below the assay’s quantification limit problematic for calculating the peak-to-trough ratio?

Solutions. (1) The average is \(50/10=5.00\) mg/L. Fluctuation is \([(7.0-3.0)/5.00]\times100\%=80.0\%\), and the ratio is \(7.0/3.0=2.333\). (2) Here \(k\tau=0.80\), so the predicted fluctuation is \(100(0.80)=80.0\%\), and the ratio is \(e^{0.80}=2.226\). (3) Sampling can miss the time of the true peak, particularly if samples are sparse around the expected maximum; the observed maximum is then only the largest measured value. (4) The true trough is not known exactly. Substituting zero makes the ratio undefined, while substituting an arbitrary value can distort it substantially.